Bosch to Launch New Capsule Filling Machine
![](/46/pdcnewsitem/03/42/65/zHiy08Xd0CctgcW.jpg)
At this year’s Achema, Bosch Packaging Technology will launch its new capsule filling machine, the GKF 2600. This high-performance machine doses powders, pellets, tablets and liquids, as well as combinations precisely and reliably. An output of up to 2600 capsules/ minute can be achieved. “The newly developed GKF 2600 combines proven and new technologies at higher outputs,” Karl-Heinz Kappes, product manager at Bosch Packaging Technology, underlines. “The machine is equipped with new filling technologies for different products, an optimized drive concept, significantly enhanced sensor technology for process control, as well as a demand-oriented containment concept.” Due to its extended machine platform and very good accessibility, the capsule filling machine can be adapted to fill different products in a very short time. Thanks to these characteristics, add-on modules can also be integrated quickly and easily.
New Development with Numerous Expansion Possibilities
The development of the new capsule filling machine is consistently based on the demands of the pharmaceutical industry and profits from the long-term experience of Bosch in capsule filling operations. “With its standard functions, the GKF 2600 fulfills the industry requirements regarding precise and reliable capsule filling. This includes, for instance, an automatic anti troubleshooting (ASB) function, as well as user-friendly handling with improved accessibility of the filling stations,” says Kappes. The optimized containment with more tightly sealed doors further ensures that the highest hygiene standards are maintained during production.
Apart from the standard functions, numerous options are available, such as the new capsule checkweigher KKE 2600 with enhanced product control. In addition, the GKF 2600 can be upgraded with a feedback loop, which automatically regulates overfilling and underfilling of capsules via tendency control of the KKE. An inspection unit can further be integrated into the capsule filling machine. It conducts weight and quality inspections with x-ray technology and an x-ray sensor. “Reliable micro-dosing of powders is crucial, especially for highly effective products that require an exact medication,” Kappes explains. “The micro-dosing wheel of the GKF 2600 precisely processes products in a filling range of two to 30 mg.” Depending on customer requirements and product characteristics, the capsule filling machine can be upgraded for different containment requirements. “The combination of highly developed standard functions and versatile add-on possibilities makes the GKF 2600 a future-proof solution for a broader product spectrum,” Kappes concludes.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance